Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Smith Hunter C sold 62,774 Rhythm Pharmaceuticals, Inc. shares (Form 4)
Traded Aug 31, 2026 · Filed Sep 1, 2026
On Aug 31, 2026, Smith Hunter C (Chief Financial Officer) sold 62,774 Rhythm Pharmaceuticals, Inc. shares at an average US$105.46 for US$6.62M under a trading plan, leaving 114,024 shares. Filed Sep 1, 2026 (Form 4).
- Sold
- 62,774 shares
- Price
- US$105.46 average (US$104.59 to US$106.20)
- Value
- US$6.62M
- Holding after
- 114,024 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Option exercise | 57,187 | US$25.79 | 176,798 | Direct |
| Aug 31, 2026 | Common Stock | Sale | 23,072 | US$104.59 | 153,726 | Direct |
| Aug 31, 2026 | Common Stock | Sale | 11,514 | US$105.37 | 142,212 | Direct |
| Aug 31, 2026 | Common Stock | Sale | 28,188 | US$106.20 | 114,024 | Direct |
Source
Related
- Rhythm Pharmaceuticals, Inc.
- Smith Hunter C
- Rhythm Pharmaceuticals, Inc. shareholders
- Form 4 · Smith Hunter C · May 20, 2026
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Shulman Joseph · Aug 17, 2026
- Form 4 · Garfield Alastair · Aug 17, 2026
- Form 4 · Lee Jennifer Kayden · Aug 14, 2026